OrganoTherapeutics
OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed OrganoTherapeutics Information
Geographic Data
Address:
City: Esch-sur-alzette
State: Luxembourg
Zip:
Country: Luxembourg
Financial Info
Stage:
non equity assistance
Raised Last:
$0
Raised Total:$0
Social
Metrics
5,235,849Website Global Rank
1,558Website Monthly Traffic
Twitter Followers
Description
OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary human-specific minibrains which represent a model mimicking faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | Non Equity Assistance | 2 | - |
Creative Destruction Lab (CDL) MassChallenge Creative Destruction Lab (CDL) MassChallenge |
10/2020 | Non Equity Assistance | 2 | - |
Creative Destruction Lab (CDL) MassChallenge Creative Destruction Lab (CDL) MassChallenge |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
